Allogene Therapeutics is a clinical-stage immuno-oncology company developing genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. The company focuses on creating off-the-shelf therapies derived from healthy donors for use in any patient.
Description via Wikipedia
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.